Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373854 · ClinicalTrials.gov registry record
Study of How Low Blood Sugar Affects the Way Blood Vessels Work
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 13
- Enrollment target
NCT00373854: Completed study, sponsored by Ohio State University.
NCT00373854 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00373854 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
Hypothesis: Low blood sugar (hypoglycemia) decreases function of the lining of the blood vessels in normal humans. This study is designed to explore how hypoglycemia affects the function of the blood vessel lining. This will be determined by measuring blood flow to the arm before and after occlusion of flow. Blood vessel function will be measured before induction of hypoglycemia, during insulin induced hypoglycemia, and after recovery from hypoglycemia. A second study will be done but without hypoglycemia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-09 |
What the finished NCT00373854 record still lists
NCT00373854 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00373854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00373854 about?
NCT00373854 is a clinical study titled "Study of How Low Blood Sugar Affects the Way Blood Vessels Work". Hypothesis: Low blood sugar (hypoglycemia) decreases function of the lining of the blood vessels in normal humans. This study is designed to explore how hypoglycemia affects the function of the blood vessel lining. This will be determined by measuring blood flow to the arm before and after occlusio...
What is the current status of trial NCT00373854?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2005-09. Estimated completion is 2006-09.
Who is sponsoring clinical trial NCT00373854?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia